Chronic pain and mobility outcomes following primary hip arthroplasty. A comparison of intravenous morphine with lumbar plexus levobupivacaine. - Chronic pain and mobility outcomes following primary hip arthroplasty

• Conditions: Acute and chronic pain following hip replacement surgery

• Registration Number: EUCTR2009-015840-40-GB
• Lead Sponsor: Belfast Health and Social Care Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09-17
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion criteria

i)ASA class I-III
American Society of Anesthesiologists classification system for all patients undergoing anaesthesia
Class I - normal healthy patient
Class II - patient with mild systemic disease
Class III - patient with severe systemic disease

ii)Age > 18yr < 85yr

iii)Patient able to give written, informed consent

iv) Patient requiring primary hip arthroplasty

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Exclusion criteria

i)History of dementia

ii)ASA class IV-V
Class IV - patient with severe systemic disease which is a constant threat to life
Class V - patient who is not expected to survive without the operation

iii)History of allergy to any of the medications used in the study.

iv)Inflammatory polyarthritis of a severity likely to compromise postoperative mobility

v)Contraindication to regional anaesthesia

vi)Patients suffering from severe hypotension such as cardiogenic or hypovolaemic shock or with a serious cardiac arrhythmia

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified